NCT00429247View on ClinicalTrials.gov

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

Trastuzumab

Trastuzumab,first administration at the dose of 8mg/Kg IV, subsequent administrations at the dose of 6mg/Kg IV,every 3 weeks for 6 cycles

Trial Locations (1)

71110

University Hospital of Crete, Heraklion

All Listed Sponsors
lead

University Hospital of Crete

OTHER

NCT00429247 - Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | Biotech Hunter | Biotech Hunter